Endoscopic Vessel Harvesting Market - Global Forecast 2025-2032

Senior decision-makers are advancing operational efficiency in the endoscopic vessel harvesting market by prioritizing technology integration, scalable procurement, and optimized clinical workflows across surgical settings.

Market Snapshot: Endoscopic Vessel Harvesting Market Size and Growth

In 2024, the endoscopic vessel harvesting market achieved a global value of USD 2.25 billion, set to increase to USD 2.48 billion in 2025 and reach USD 4.85 billion by 2032. With a steady 10.03% compound annual growth rate, this market reflects expanding adoption of minimally invasive techniques and advanced device platforms. Companies are accelerating the deployment of integrated systems that streamline clinical operations, support regulatory compliance, and help improve patient care across a range of facilities. The focus remains clear: deliver robust, workflow-driven solutions that meet the evolving expectations of healthcare providers seeking consistency and scalability.

Scope & Segmentation of the Endoscopic Vessel Harvesting Market

• Product Categories: Encompasses a comprehensive spectrum of devices, including both single-use and reusable surgical instruments, plus essential accessories such as adapters, cannulas, and insufflation tubing.
• Technologies: Features both automated systems with advanced insufflation and suction capabilities and manual solutions, catering to facilities with different technology resources and clinical program needs.
• End Users: Serves a variety of healthcare environments, including ambulatory surgical centers, hospitals, independent surgical facilities, community care organizations, and academic medical centers, supporting distinct cardiac and multidisciplinary requirements.
• Applications: Supports a diverse set of procedures such as coronary artery bypass grafting, peripheral interventions, dialysis access creation, and lower limb reconstruction, broadening its relevance across surgical specialties.
• Regions: Covers the Americas, Europe, Middle East and Africa, and Asia-Pacific (including Australia), each with unique regulatory frameworks, clinical standards, and market strategies that shape local adoption.
• Key Companies: Major innovators and suppliers include Medtronic plc, Getinge AB, Terumo Corporation, B. Braun Melsungen AG, LivaNova PLC, CryoLife, Inc., Teleflex Incorporated, Johnson & Johnson, Abbott Laboratories, and Stryker Corporation, each contributing to technological advancement and regional market dynamics.

Key Takeaways for Senior Market Decision-Makers

• Modern endoscopic vessel harvesting technologies integrate smoothly into both high-capacity cardiac centers and facilities managing resource constraints, providing the flexibility and scalability needed to adapt to shifting clinical demands.
• Utilization of single-use instruments together with automated workflow platforms enhances procedural reliability, enables infection control, and helps align procurement practices with present-day healthcare protocols.
• Procurement approaches are adapting to include regulatory compliance and economic pressures, with organizations favoring device compatibility with a range of care delivery structures.
• Significant variation in regional healthcare standards and reimbursement models requires strategic adaptation for successful market entry and long-term sustainability.
• Ongoing collaboration among device manufacturers, digital health partners, and service providers enhances workforce training, fosters evidence-based procurement processes, and drives improvements in workflow management and clinical outcomes.

Tariff Impact: Navigating the United States 2025 Tariffs

Forthcoming 2025 tariffs on endoscopic vessel harvesting equipment are increasing supply chain expenses for U.S. manufacturers and healthcare institutions. In response, industry leaders are localizing manufacturing, forming partnerships with domestic vendors, and adjusting sourcing policies to mitigate rising costs. Procurement teams are renegotiating supplier agreements and leveraging analytics tools for more efficient inventory tracking. Strong commercial partnerships are vital to maintaining stable technology access and operational continuity during regulatory shifts.

Methodology & Data Sources

This analysis employs a structured, multi-stage research approach. It integrates secondary data from clinical trial registries, regulatory filings, patent records, and peer-reviewed publications, alongside primary insights collected through interviews with clinicians, engineers, and procurement experts. Device usage surveys further inform the findings, which are validated via triangulation and review by independent third parties to ensure data accuracy.

Why This Report Matters

• Delivers actionable intelligence for procurement, technology, and executive teams seeking to optimize investments in endoscopic vessel harvesting devices amid evolving operational and regulatory conditions.
• Highlights technology adoption and workflow improvement across varied healthcare environments, helping organizations streamline care processes and allocate resources efficiently.
• Supports resilience by preparing stakeholders for regulatory, clinical, and supply-side developments, facilitating the successful implementation of modern harvesting technologies.

Conclusion

This report enables senior healthcare leaders to make informed procurement decisions, drive operational improvements, and remain agile in a dynamic endoscopic vessel harvesting landscape.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.